resonance imaging (MRI). Future imaging options include multislice CT scanners and positron emission tomography (PET)-CT fusion studies, which may be particularly helpful in distinguishing compression fractures from pathologic fractures. Biomarkers in Bone
Search Results
Richard L. Theriault, J. Sybil Biermann, Elizabeth Brown, Adam Brufsky, Laurence Demers, Ravinder K. Grewal, Theresa Guise, Rebecca Jackson, Kevin McEnery, Donald Podoloff, Peter Ravdin, Charles L. Shapiro, Matthew Smith, and Catherine H. Van Poznak
Al B. Benson III, Tanios Bekaii-Saab, Emily Chan, Yi-Jen Chen, Michael A. Choti, Harry S. Cooper, Paul F. Engstrom, Peter C. Enzinger, Marwan G. Fakih, Charles S. Fuchs, Jean L. Grem, Steven Hunt, Lucille A. Leong, Edward Lin, Michael G. Martin, Kilian Salerno May, Mary F. Mulcahy, Kate Murphy, Eric Rohren, David P. Ryan, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, William Small Jr, Constantinos T. Sofocleous, Alan P. Venook, Christopher G. Willett, Deborah A. Freedman-Cass, and Kristina M. Gregory
and MRI, enables preoperative assessments of depth of tumor penetration and the presence of local lymph nodal metastases. 78 The consensus of the panel is that a PET scan is not routinely indicated. Additional information regarding the extent of
Ronald S. Go, Eric Jacobsen, Robert Baiocchi, Ilia Buhtoiarov, Erin B. Butler, Patrick K. Campbell, Don W. Coulter, Eli Diamond, Aron Flagg, Aaron M. Goodman, Gaurav Goyal, Dita Gratzinger, Paul C. Hendrie, Meghan Higman, Michael D. Hogarty, Filip Janku, Reem Karmali, David Morgan, Anne C. Raldow, Alexandra Stefanovic, Srinivas K. Tantravahi, Kelly Walkovich, Ling Zhang, Mary Anne Bergman, and Susan D. Darlow
’s LCH is single or multisystem is unknown in the absence of staging. Therefore, whole-body PET/CT should be considered for patients with suspected multisystem disease. Abnormal brain MRI is often observed in LCH, even in the absence of neurologic
Filipa Lynce and Claudine Isaacs
-reducing mastectomies. 5 , 6 Additionally, risk-reducing surgeries have been shown to be the most cost-effective measures. Using costs, life-years (LY), and quality-adjusted life-years (QALY) as outcomes, a study that compared preventive surgery, chemoprevention, MRI
Stephen Pereira
(eg, ultrasonography, CT, MRI), explained Dr. Pereira. A predictable zone of biologic change is present around the fibers, he added, with no unacceptable effects on surrounding tissues. Bown et al 7 performed a phase I study of mTH-PC-mediated PDT
John M. Skibber
Ramsey C . Comparison of CT and MRI in the pre-operative staging of rectal adenocarcinoma and prediction of circumferential resection margin involvement by MRI . Colorectal Dis 2003 ; 5 : 396 - 401 . 19 Fuchsjager MH Maier AG Schima W
Harry T. Whelan
, radiotherapy, and/or chemotherapy.” As documented on MRI, tumor responses were seen in all of the patients, and the mean time to tumor progression after PDT was 67 weeks. 2 “If you subtract out the blood–brain barrier breakdown, you still have cell
Joseph G. Rajendran and Benjamin E. Greer
. 15. Narayan K Hicks RJ Jobling T . A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment . Int J Gynecol Cancer 2001 ; 11 : 263 – 271 . 16. Grigsby PW
James L. Mohler and Emmanuel S. Antonarakis
molecular-based test, 3P MRI, restaging prostate biopsy, surveillance 3P MRI, surveillance prostate biopsies, some combination thereof, or prospective clinical trials. 1 Androgen Deprivation Therapy “I am an advocate of using less androgen deprivation
Presenter: Sandy Srinivas
therapy in bone disease, Dr. Srinivas explained. Conventional imaging techniques, such as bone scans, MRI, and CT, have shortcomings that appear to be overcome by more modern PET techniques. “Bone scans are not specific to prostate cancer and don
